CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Seeking Alpha Healthcare
Original article

Jupiter Neurosciences acquires U.S. rights to ALA-002 in deal worth up to $100M

ALA-002Positive
AI Analysis

Summary

Jupiter Neurosciences acquires U.S. rights to ALA-002 in a deal valued at up to $100 million, expanding its neuroscience pipeline.

Importance:7/10
Sentiment:
0.60
M&Aacquisitionlicensingneuroscience
Related Companies

Read the original article

Published by Seeking Alpha Healthcare on July 21, 2026 12:20 PM

Read Original